News

In a July 8, 2013 press release, researchers at the University of Kentucky Sanders-Brown Center on Aging, led by Donna Wilcock, announced they have recently published a new paper in the Journal of Neuroscience detailing an advance in treatment for Alzheimer's disease.

The Gammagard IVIg is a therapy that has been investigated in the treatment of Alzheimer's, but was poorly understood. The UK researchers started investigating the mechanism in regard to how it acts in the brain to decrease deposits of amyloid, a key element in Alzheimer's pathology.

The complete article can be found through Genetic Engineering and Biotechnology News.

NIH says it will improve its Clinical and Translational Science Awards (CTSA) program by strengthening its leadership, standardizing the evaluation of centers, increasing collaboration, ramping up its engagement with patient groups, and enhancing its transparency-based on recommendations made yesterday by theInstitute of Medicine(IOM).

From the June 25, 2013 press release: DiaTech Oncology, a life sciences and clinical pathology laboratory company based in Nashville, Tenn., today announced that the company has received a Clinical Laboratory Permit from the New York State Department of Health (NYS DOH).

Taken from the Science Daily article.

Humans and their pet dogs are close, so close that they both develop a type of cancer called diffuse large B-cell lymphoma. In humans it's the most common lymphoma subtype while in dogs, it's one of the most common cancers in veterinary oncology.

Taken from the Genetic Engineering and Biotechnology News clip:

Less than two weeks afterthe Supreme Court struck down its gene patents,Myriad Geneticshas moved on, inking an agreement withcancer-focused biopharmaceutical companyTesaroto conductBRCA1andBRCA2mutation testing on patients to be enrolled in two separate Phase III clinical studies evaluating the PARP inhibitorniraparib.